Advertisement
Advertisement
PRLD
Prelude Therapeutics Incorporated
3.60
USDSponsored
+0.04
+1.27%
Nov 06, 15:59 UTC -5
Closed
After-Market
3.65
+0.05
+1.39%
Prelude Therapeutics Incorporated (PRLD)
Prelude Therapeutics Incorporated Financial Snapshot
| Market Cap | 291.28M |
| Beta | 1.22 |
| Earnings Per Share (EPS) | -0.73 |
| Price-to-Book (P/B) Ratio | 2.15 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -75.35% |
| Current Ratio | 4.07% |
| Free Cash Flow | -37.26M |
